摘要
血糖变异性被大量研究证实与糖尿病患者的血糖管理水平和临床预后显著相关,而目标范围内时间(TIR)作为动态血糖监测(CGM)报告中评估短期血糖变异性的关键指标之一,在近年来也逐渐引起临床重视。综合多维度的血糖管理成为糖尿病患者更为优化的治疗模式。
A large number of studies have confirmed that glycemic variability is significantly correlated with blood glucose management and clinical prognosis in diabetes.As one of the key indicators for evaluating short-term glycemic variability in CGM reports,Time in Range(TIR)has gradually attracted clinical attention in recent years.Comprehensive multi-dimensional blood glucose management has become a more optimal treatment mode for diabetes.
作者
陆菊明
LU Juming(Department of Endocrinology,The First Medical Center of PLA General Hospital,Beijing 100853,China.)
出处
《药品评价》
CAS
2020年第20期1-3,共3页
Drug Evaluation
关键词
共识
糖尿病
血糖变异性
TIR
德谷胰岛素
Consensus
Diabetes
Blood Glucose Variability
Time In Range
Degludec Insulin